OverviewSuggest Edit

Biohit, a biotechnology company, produces diagnostic tests and analysis systems for use in research institutions and healthcare industries worldwide. Its diagnostic tests product range includes the blood-sample based GastroPanel test for diagnosing diseases of the stomach and associated risks; quick tests for the diagnosis of lactose intolerance, Helicobacter pylori infection, and Celiac disease; and ColonView for the early detection of fecal occult blood. The Company's diagnostic tests are also used for the identification of patients at increased risk of gastric cancer, peptic ulcer disease, and gastroesophageal reflux disease, as well as deficiencies of vitamin B12, calcium, and iron.

TypePublic
Founded1988
HQHelsinki, FI
Websitebiohithealthcare.com

Latest Updates

Employees (est.) (Feb 2019)51
Share Price (Jun 2020)€2.6 (+2%)
Cybersecurity ratingAMore

Key People/Management at Biohit

Semi Korpela

Semi Korpela

President & CEO
Ilari Patrakka

Ilari Patrakka

Sales & Marketing Director
Show more

Biohit Office Locations

Biohit has offices in Helsinki, Milano and Cheshire
Helsinki, FI (HQ)
Laippatie 1
Milano, IT
Via Boncompagni, 3
Cheshire, GB
Pioneer Business Park, Pioneer House, North Rd
Show all (3)

Biohit Financials and Metrics

Biohit Revenue

Market capitalization (27-Apr-2020)

41.4m

Closing stock price (27-Apr-2020)

2.8
Biohit's current market capitalization is €41.4 m.
Show all financial metrics

Biohit Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Biohit Online and Social Media Presence

Embed Graph

Biohit News and Updates

Biohit Colonview Quick Test product improvement – a new Control reagent

Biohit Oyj Press release 26.6.2019 at 14.15 local time (EEST)

Biohit Plc - Managers' transactions - Söderström

Person subject to the notification requirementName: Söderström, DanielaPosition: Other senior managerIssuer: Biohit PlcLEI: 74370089ATTSNBXJVT29      Notification type: INITIAL NOTIFICATIONReference number: 74370089ATTSNBXJVT29_20190603065401_4            

Decisions of the Annual General Meeting of Biohit Oyj

Biohit Oyj: Decisions of the Annual General Meeting April 24, 2019 at 7:30 pm local time (EET)
Show more

Biohit Frequently Asked Questions

  • When was Biohit founded?

    Biohit was founded in 1988.

  • Who are Biohit key executives?

    Biohit's key executives are Semi Korpela and Ilari Patrakka.

  • How many employees does Biohit have?

    Biohit has 51 employees.

  • Who are Biohit competitors?

    Competitors of Biohit include Sartorius, Response Biomedical and Laboratory Corporation of America Holdings.

  • Where is Biohit headquarters?

    Biohit headquarters is located at Laippatie 1, Helsinki.

  • Where are Biohit offices?

    Biohit has offices in Helsinki, Milano and Cheshire.

  • How many offices does Biohit have?

    Biohit has 3 offices.